Susanne Hille

Comprehensive plasma and tissue profiling reveals systemic metabolic alterations in cardiac hypertrophy and failure.

Circulating uromodulin inhibits vascular calcification by interfering with pro-inflammatory cytokine signalling.

Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants.

Alginate hydrogel polymers enable efficient delivery of a vascular-targeted AAV vector into aortic tissue.

FYCO1 Regulates Cardiomyocyte Autophagy and Prevents Heart Failure Due to Pressure Overload In Vivo.

Cardiac Fibroblast Growth Factor 23 Excess Does Not Induce Left Ventricular Hypertrophy in Healthy Mice.

AKAP18δ Anchors and Regulates CaMKII Activity at Phospholamban-SERCA2 and RYR.

Reduction of A-to-I RNA editing in the failing human heart regulates formation of circular RNAs.

Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders.